FDA advisory panel rejects widespread Pfizer booster shots
Members of the Food and Drug Administration panel of outside experts voiced frustration that Pfizer had provided little data on safety of extra doses. The post FDA advisory panel r…
Members of the Food and Drug Administration panel of outside experts voiced frustration that Pfizer had provided little data on safety of extra doses. The post FDA advisory panel r…